Kevin Feeley, CFO of GeneDx Holdings Corp. ($WGS), sold about $7.9 million in company shares across 61 open market transactions over the past year, with the latest on March 9, 2026. This ranks him 1,361st among 11,678 insiders by total sales value, below the average of $8.6 million per seller and far above the typical 6 transactions. He made no open market purchases in that period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2520 | $63.28 | 37,432.0000 | 28,904,590 | 6.31% | 0.01% |
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 961 | $62.33 | 39,952.0000 | 28,904,590 | 2.35% | 0.00% |
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2485 | $61.29 | 40,913.0000 | 28,904,590 | 5.73% | 0.01% |
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 16250 | $0.00 | 43,398.0000 | 28,904,590 | 59.86% | 0.06% |
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 16250 | $0.00 | 32,500.0000 | 28,904,590 | 33.33% | 0.06% |
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1857 | $65.21 | 34,580.0000 | 28,904,590 | 5.10% | 0.01% |
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 995 | $64.60 | 36,437.0000 | 28,904,590 | 2.66% | 0.00% |
| March 16, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2384 | $76.35 | 30,470.0000 | 28,904,590 | 7.26% | 0.01% |
| March 16, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 257 | $77.94 | 27,148.0000 | 28,904,590 | 0.94% | 0.00% |
| March 15, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 3815 | $0.00 | 11,446.0000 | 28,904,590 | 25.00% | 0.01% |
| March 16, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 7197 | $0.00 | 28,787.0000 | 28,904,590 | 20.00% | 0.02% |
| March 16, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 3065 | $77.05 | 27,405.0000 | 28,904,590 | 10.06% | 0.01% |
| March 16, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 7197 | $0.00 | 32,854.0000 | 28,904,590 | 28.05% | 0.02% |
| March 15, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 3815 | $0.00 | 25,657.0000 | 28,904,590 | 17.47% | 0.01% |
| March 9, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 2462 | $0.00 | 23,122.0000 | 28,904,590 | 11.92% | 0.01% |
| March 9, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 2462 | $0.00 | 7,387.0000 | 28,904,590 | 25.00% | 0.01% |
| March 9, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1280 | $86.75 | 21,842.0000 | 28,904,590 | 5.54% | 0.00% |
| March 6, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | A | Class A Common Stock | 1986 | $88.11 | 20,660.0000 | 28,904,590 | 10.64% | 0.01% |
| March 3, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | A | Restricted Stock Unit | 10865 | $0.00 | 10,865.0000 | 28,904,590 | 9999.99% | 0.04% |
| March 4, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2220 | $79.25 | 18,674.0000 | 28,904,590 | 10.63% | 0.01% |
| March 4, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1424 | $77.63 | 23,437.0000 | 28,904,590 | 5.73% | 0.00% |
| March 3, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | A | Class A Common Stock | 15262 | $0.00 | 24,861.0000 | 28,904,590 | 159.00% | 0.05% |
| March 4, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2543 | $78.61 | 20,894.0000 | 28,904,590 | 10.85% | 0.01% |
| March 2, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 287 | $77.52 | 9,599.0000 | 28,904,590 | 2.90% | 0.00% |
| March 1, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 718 | $0.00 | 1,434.0000 | 28,904,590 | 33.36% | 0.00% |
| March 1, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 718 | $0.00 | 9,886.0000 | 28,904,590 | 7.83% | 0.00% |
| Jan. 29, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2 | $92.06 | 9,168.0000 | 28,904,590 | 0.02% | 0.00% |
| Jan. 29, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 754 | $0.00 | 754.0000 | 28,904,590 | 50.00% | 0.00% |
| Jan. 29, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 754 | $0.00 | 9,485.0000 | 28,904,590 | 8.64% | 0.00% |
| Jan. 29, 2026 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 315 | $94.00 | 9,170.0000 | 28,904,590 | 3.32% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 7197 | $0.00 | 12,586.0000 | 28,904,590 | 133.55% | 0.02% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 131 | $138.93 | 12,455.0000 | 28,904,590 | 1.04% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 366 | $140.08 | 12,089.0000 | 28,904,590 | 2.94% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 951 | $141.20 | 11,138.0000 | 28,904,590 | 7.87% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 215 | $142.12 | 10,923.0000 | 28,904,590 | 1.93% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 334 | $144.27 | 10,589.0000 | 28,904,590 | 3.06% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 578 | $145.36 | 10,011.0000 | 28,904,590 | 5.46% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 699 | $146.93 | 9,312.0000 | 28,904,590 | 6.98% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 331 | $148.55 | 8,981.0000 | 28,904,590 | 3.55% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 97 | $149.20 | 8,884.0000 | 28,904,590 | 1.08% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 26 | $150.75 | 8,858.0000 | 28,904,590 | 0.29% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 127 | $140.45 | 8,731.0000 | 28,904,590 | 1.43% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 7197 | $0.00 | 35,984.0000 | 28,904,590 | 16.67% | 0.02% |
| Dec. 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 2462 | $0.00 | 6,655.0000 | 28,904,590 | 58.72% | 0.01% |
| Dec. 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 2462 | $0.00 | 9,849.0000 | 28,904,590 | 20.00% | 0.01% |
| Dec. 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1266 | $159.28 | 5,389.0000 | 28,904,590 | 19.02% | 0.00% |
| Dec. 1, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 717 | $0.00 | 4,570.0000 | 28,904,590 | 18.61% | 0.00% |
| Dec. 1, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 377 | $162.54 | 4,193.0000 | 28,904,590 | 8.25% | 0.00% |
| Dec. 1, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 717 | $0.00 | 2,152.0000 | 28,904,590 | 24.99% | 0.00% |
| Oct. 29, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 388 | $136.54 | 3,757.0000 | 28,904,590 | 9.36% | 0.00% |
| Oct. 29, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 753 | $0.00 | 4,145.0000 | 28,904,590 | 22.20% | 0.00% |
| Oct. 29, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 753 | $0.00 | 1,508.0000 | 28,904,590 | 33.30% | 0.00% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Employee Stock Option (Right to Buy) | 1246 | $0.00 | 4,982.0000 | 28,068,274 | 20.01% | 0.00% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 520 | $111.93 | 3,462.0000 | 28,068,274 | 13.06% | 0.00% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 421 | $110.05 | 3,982.0000 | 28,068,274 | 9.56% | 0.00% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2152 | $108.67 | 4,403.0000 | 28,068,274 | 32.83% | 0.01% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2715 | $107.68 | 6,555.0000 | 28,068,274 | 29.29% | 0.01% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 387 | $106.86 | 9,270.0000 | 28,068,274 | 4.01% | 0.00% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 344 | $105.24 | 9,657.0000 | 28,068,274 | 3.44% | 0.00% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 1246 | $32.67 | 10,001.0000 | 28,068,274 | 14.23% | 0.00% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 70 | $113.68 | 3,392.0000 | 28,068,274 | 2.02% | 0.00% |
| Sept. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 7197 | $0.00 | 12,483.0000 | 28,068,274 | 136.15% | 0.03% |
| Sept. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 7197 | $0.00 | 43,181.0000 | 28,068,274 | 14.29% | 0.03% |
| Sept. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 3728 | $121.47 | 8,755.0000 | 28,068,274 | 29.86% | 0.01% |
| Sept. 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 7197 | $0.00 | 12,483.0000 | 28,068,274 | 36.57% | 0.03% |
| Sept. 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 2462 | $0.00 | 6,558.0000 | 28,068,274 | 60.11% | 0.01% |
| Sept. 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 2462 | $0.00 | 12,311.0000 | 28,068,274 | 16.67% | 0.01% |
| Sept. 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 6 | $129.09 | 5,286.0000 | 28,068,274 | 0.11% | 0.00% |
| Sept. 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1266 | $128.05 | 5,292.0000 | 28,068,274 | 19.30% | 0.00% |
| Sept. 2, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 378 | $125.81 | 4,096.0000 | 28,068,274 | 8.45% | 0.00% |
| Sept. 1, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 717 | $0.00 | 2,869.0000 | 28,068,274 | 19.99% | 0.00% |
| Sept. 1, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 717 | $0.00 | 4,474.0000 | 28,068,274 | 19.08% | 0.00% |
| July 29, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 753 | $0.00 | 4,145.0000 | 28,068,274 | 22.20% | 0.00% |
| July 29, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 753 | $0.00 | 2,261.0000 | 28,068,274 | 24.98% | 0.00% |
| July 29, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 388 | $105.31 | 3,757.0000 | 28,068,274 | 9.36% | 0.00% |
| July 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Employee Stock Option (Right to Buy) | 1245 | $0.00 | 6,228.0000 | 28,068,274 | 16.66% | 0.00% |
| July 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 5278 | $93.00 | 3,392.0000 | 28,068,274 | 60.88% | 0.02% |
| July 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 1245 | $32.67 | 8,670.0000 | 28,068,274 | 16.77% | 0.00% |
| July 1, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 346 | $91.88 | 7,425.0000 | 28,068,274 | 4.45% | 0.00% |
| July 1, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 998 | $90.86 | 7,771.0000 | 28,068,274 | 11.38% | 0.00% |
| June 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 3729 | $64.77 | 8,769.0000 | 28,068,274 | 29.84% | 0.01% |
| June 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 7197 | $0.00 | 12,498.0000 | 28,068,274 | 36.54% | 0.03% |
| June 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 7197 | $0.00 | 50,378.0000 | 28,068,274 | 12.50% | 0.03% |
| June 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 2462 | $0.00 | 14,773.0000 | 28,068,274 | 14.28% | 0.01% |
| June 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1266 | $72.55 | 5,301.0000 | 28,068,274 | 19.28% | 0.00% |
| June 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 2462 | $0.00 | 6,567.0000 | 28,068,274 | 59.98% | 0.01% |
| June 1, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 718 | $0.00 | 4,475.0000 | 28,068,274 | 19.11% | 0.00% |
| June 2, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 370 | $71.26 | 4,105.0000 | 28,068,274 | 8.27% | 0.00% |
| June 1, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 718 | $0.00 | 3,586.0000 | 28,068,274 | 16.68% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 637 | $83.67 | 16,605.0000 | 28,068,274 | 3.69% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1198 | $84.61 | 15,407.0000 | 28,068,274 | 7.21% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1171 | $85.73 | 14,236.0000 | 28,068,274 | 7.60% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 249 | $86.48 | 13,987.0000 | 28,068,274 | 1.75% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 5993 | $93.28 | 7,994.0000 | 28,068,274 | 42.85% | 0.02% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2693 | $94.61 | 5,301.0000 | 28,068,274 | 33.69% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1463 | $95.53 | 3,838.0000 | 28,068,274 | 27.60% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 846 | $96.46 | 2,992.0000 | 28,068,274 | 22.04% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 20 | $97.26 | 2,972.0000 | 28,068,274 | 0.67% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Employee Stock Option (Right to Buy) | 1246 | $0.00 | 7,473.0000 | 28,068,274 | 14.29% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 1246 | $32.67 | 17,242.0000 | 28,068,274 | 7.79% | 0.00% |
| April 29, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 388 | $113.09 | 3,337.0000 | 28,068,274 | 10.42% | 0.00% |
| April 30, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | A | Class A Common Stock | 420 | $56.82 | 3,757.0000 | 28,068,274 | 12.59% | 0.00% |
| April 29, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 753 | $0.00 | 3,014.0000 | 28,068,274 | 19.99% | 0.00% |
| April 29, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 753 | $0.00 | 3,725.0000 | 28,068,274 | 25.34% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 20 | $97.26 | 1,726.0000 | 28,068,274 | 1.15% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 846 | $96.46 | 1,746.0000 | 28,068,274 | 32.64% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1463 | $95.53 | 2,592.0000 | 28,068,274 | 36.08% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 3122 | $94.60 | 4,055.0000 | 28,068,274 | 43.50% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 6810 | $93.26 | 7,177.0000 | 28,068,274 | 48.69% | 0.02% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 249 | $86.48 | 13,987.0000 | 28,068,274 | 1.75% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1171 | $85.73 | 14,236.0000 | 28,068,274 | 7.60% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1198 | $84.61 | 15,407.0000 | 28,068,274 | 7.21% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 637 | $83.67 | 16,605.0000 | 28,068,274 | 3.69% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 1246 | $32.67 | 17,242.0000 | 28,068,274 | 7.79% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Employee Stock Option (Right to Buy) | 1246 | $0.00 | 7,473.0000 | 28,068,274 | 14.29% | 0.00% |
| March 26, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 8418 | $95.66 | 16,324.0000 | 28,068,274 | 34.02% | 0.03% |
| March 26, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 16250 | $0.00 | 24,742.0000 | 28,068,274 | 191.36% | 0.06% |
| March 26, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 328 | $94.40 | 15,996.0000 | 28,068,274 | 2.01% | 0.00% |
| March 26, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 16250 | $0.00 | 48,750.0000 | 28,068,274 | 25.00% | 0.06% |
| March 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 7197 | $0.00 | 57,575.0000 | 28,068,274 | 11.11% | 0.03% |
| March 13, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 402 | $90.05 | 5,044.0000 | 28,068,274 | 7.38% | 0.00% |
| March 16, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 7197 | $0.00 | 12,241.0000 | 28,068,274 | 37.03% | 0.03% |
| March 17, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 3749 | $96.71 | 8,492.0000 | 28,068,274 | 30.63% | 0.01% |
| March 26, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | A | Restricted Stock Unit | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | A | Restricted Stock Unit | 15261 | $0.00 | 15,261.0000 | 28,068,274 | 9999.99% | 0.05% |
| March 10, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 922 | $94.72 | 5,446.0000 | 28,068,274 | 14.48% | 0.00% |
| March 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 2462 | $0.00 | 6,368.0000 | 28,068,274 | 63.03% | 0.01% |
| March 9, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 2462 | $0.00 | 17,235.0000 | 28,068,274 | 12.50% | 0.01% |
| March 3, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 261 | $103.94 | 3,906.0000 | 28,068,274 | 6.26% | 0.00% |
| March 1, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 717 | $0.00 | 4,167.0000 | 28,068,274 | 20.78% | 0.00% |
| March 1, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 717 | $0.00 | 4,034.0000 | 28,068,274 | 15.09% | 0.00% |
| Jan. 29, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 275 | $78.48 | 2,950.0000 | 0 | 8.53% | 0.00% |
| Jan. 29, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 753 | $0.00 | 3,225.0000 | 0 | 30.46% | 0.00% |
| Jan. 29, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 753 | $0.00 | 3,767.0000 | 0 | 16.66% | 0.00% |
| Jan. 7, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 900 | $96.52 | 2,472.0000 | 0 | 26.69% | 0.00% |
| Jan. 7, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 11208 | $32.67 | 37,978.0000 | 0 | 41.87% | 0.00% |
| Jan. 7, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 24073 | $93.32 | 13,905.0000 | 0 | 63.39% | 0.00% |
| Jan. 7, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 7078 | $94.28 | 6,827.0000 | 0 | 50.90% | 0.00% |
| Jan. 7, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 3455 | $95.62 | 3,372.0000 | 0 | 50.61% | 0.00% |
| Jan. 7, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Employee Stock Option (Right to Buy) | 11208 | $0.00 | 8,719.0000 | 0 | 56.25% | 0.00% |
| Jan. 2, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 774 | $76.00 | 27,107.0000 | 0 | 2.78% | 0.00% |
| Jan. 2, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 319 | $75.08 | 27,881.0000 | 0 | 1.13% | 0.00% |
| Jan. 2, 2025 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 337 | $77.04 | 26,770.0000 | 0 | 1.24% | 0.00% |
| Dec. 16, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 3728 | $76.75 | 28,200.0000 | 0 | 11.68% | 0.00% |
| Dec. 16, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 7197 | $0.00 | 31,928.0000 | 0 | 29.10% | 0.00% |
| Dec. 16, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 7197 | $0.00 | 64,772.0000 | 0 | 10.00% | 0.00% |
| Dec. 9, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 2462 | $0.00 | 25,868.0000 | 0 | 10.52% | 0.00% |
| Dec. 9, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1137 | $76.37 | 24,731.0000 | 0 | 4.40% | 0.00% |
| Dec. 9, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 2462 | $0.00 | 19,697.0000 | 0 | 11.11% | 0.00% |
| Dec. 1, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 718 | $0.00 | 5,021.0000 | 0 | 12.51% | 0.00% |
| Dec. 1, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 718 | $0.00 | 23,669.0000 | 0 | 3.13% | 0.00% |
| Dec. 2, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 263 | $78.39 | 23,406.0000 | 0 | 1.11% | 0.00% |
| Nov. 21, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 969 | $71.86 | 43,352.0000 | 0 | 2.19% | 0.00% |
| Nov. 21, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1057 | $73.00 | 42,295.0000 | 0 | 2.44% | 0.00% |
| Nov. 21, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 5524 | $73.79 | 36,771.0000 | 0 | 13.06% | 0.00% |
| Nov. 21, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 3839 | $74.97 | 32,932.0000 | 0 | 10.44% | 0.00% |
| Nov. 22, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 5162 | $75.34 | 27,770.0000 | 0 | 15.67% | 0.00% |
| Nov. 22, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2108 | $77.40 | 22,951.0000 | 0 | 8.41% | 0.00% |
| Nov. 22, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2711 | $76.41 | 25,059.0000 | 0 | 9.76% | 0.00% |
| Nov. 21, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 200 | $69.58 | 44,751.0000 | 0 | 0.44% | 0.00% |
| Nov. 21, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 430 | $70.84 | 44,321.0000 | 0 | 0.96% | 0.00% |
| Oct. 29, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 274 | $66.60 | 44,951.0000 | 0 | 0.61% | 0.00% |
| Oct. 29, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 753 | $0.00 | 45,225.0000 | 0 | 1.69% | 0.00% |
| Oct. 29, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 753 | $0.00 | 4,520.0000 | 0 | 14.28% | 0.00% |
| Sept. 16, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2635 | $37.59 | 44,472.0000 | 0 | 5.59% | 0.00% |
| Sept. 16, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 7197 | $0.00 | 47,107.0000 | 0 | 18.03% | 0.00% |
| Sept. 16, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 7197 | $0.00 | 71,969.0000 | 0 | 9.09% | 0.00% |
| Sept. 9, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 895 | $33.33 | 39,910.0000 | 0 | 2.19% | 0.00% |
| Sept. 9, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 2462 | $0.00 | 40,805.0000 | 0 | 6.42% | 0.00% |
| Sept. 9, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 2462 | $0.00 | 22,159.0000 | 0 | 10.00% | 0.00% |
| Sept. 3, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 262 | $31.71 | 38,343.0000 | 0 | 0.68% | 0.00% |
| Sept. 1, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 717 | $0.00 | 38,605.0000 | 0 | 1.89% | 0.00% |
| Sept. 1, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 717 | $0.00 | 5,739.0000 | 0 | 11.11% | 0.00% |
| July 29, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 753 | $0.00 | 38,162.0000 | 0 | 2.01% | 0.00% |
| July 29, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 753 | $0.00 | 5,273.0000 | 0 | 12.50% | 0.00% |
| July 29, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 274 | $33.54 | 37,888.0000 | 0 | 0.72% | 0.00% |
| June 16, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 7197 | $0.00 | 40,055.0000 | 0 | 21.90% | 0.00% |
| June 16, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 7197 | $0.00 | 79,166.0000 | 0 | 8.33% | 0.00% |
| June 17, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2646 | $28.31 | 37,409.0000 | 0 | 6.61% | 0.00% |
| June 9, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 2462 | $0.00 | 33,753.0000 | 0 | 7.87% | 0.00% |
| June 10, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 895 | $24.92 | 32,858.0000 | 0 | 2.65% | 0.00% |
| June 9, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 2462 | $0.00 | 24,621.0000 | 0 | 9.09% | 0.00% |
| June 1, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 717 | $0.00 | 6,456.0000 | 0 | 10.00% | 0.00% |
| June 1, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 717 | $0.00 | 31,553.0000 | 0 | 2.33% | 0.00% |
| June 3, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 262 | $20.55 | 31,291.0000 | 0 | 0.83% | 0.00% |
| April 29, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 3013 | $0.00 | 6,026.0000 | 0 | 33.33% | 0.00% |
| April 29, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 3013 | $0.00 | 31,940.0000 | 0 | 10.42% | 0.00% |
| April 29, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1104 | $11.04 | 30,836.0000 | 0 | 3.46% | 0.00% |
| March 16, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 7197 | $0.00 | 86,363.0000 | 0 | 7.69% | 0.00% |
| March 18, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 3253 | $10.59 | 28,927.0000 | 0 | 10.11% | 0.00% |
| March 16, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 7197 | $0.00 | 32,180.0000 | 0 | 28.81% | 0.00% |
| March 12, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 931 | $9.21 | 24,983.0000 | 0 | 3.59% | 0.00% |
| March 9, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 2462 | $0.00 | 25,914.0000 | 0 | 10.50% | 0.00% |
| March 9, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 2462 | $0.00 | 27,083.0000 | 0 | 8.33% | 0.00% |
| March 1, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Unit | 718 | $0.00 | 7,173.0000 | 0 | 9.10% | 0.00% |
| March 1, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 718 | $0.00 | 23,753.0000 | 0 | 3.12% | 0.00% |
| March 4, 2024 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 301 | $8.57 | 23,452.0000 | 0 | 1.27% | 0.00% |
| Dec. 16, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Restricted Stock Unit | 7197 | $0.00 | 93,560.0000 | 0 | 7.14% | 0.00% |
| Dec. 18, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 2948 | $2.16 | 23,035.0000 | 0 | 11.35% | 0.00% |
| Dec. 16, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Class A Common Stock | 7197 | $0.00 | 25,983.0000 | 0 | 38.31% | 0.00% |
| Dec. 9, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Class A Common Stock | 2462 | $0.00 | 19,694.0000 | 0 | 14.29% | 0.00% |
| Dec. 9, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Restricted Stock Unit | 2462 | $0.00 | 29,545.0000 | 0 | 7.69% | 0.00% |
| Dec. 11, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 908 | $1.61 | 18,786.0000 | 0 | 4.61% | 0.00% |
| Dec. 1, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Class A Common Stock | 717 | $0.00 | 17,502.0000 | 0 | 4.27% | 0.00% |
| Dec. 1, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Restricted Stock Unit | 717 | $0.00 | 7,891.0000 | 0 | 8.33% | 0.00% |
| Dec. 4, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 270 | $1.77 | 17,232.0000 | 0 | 1.54% | 0.00% |
| Sept. 16, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Class A Common Stock | 7197 | $0.00 | 19,527.0000 | 0 | 58.37% | 0.00% |
| Sept. 16, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Restricted Stock Unit | 7197 | $0.00 | 100,757.0000 | 0 | 6.67% | 0.00% |
| Sept. 18, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 2742 | $4.16 | 16,785.0000 | 0 | 14.04% | 0.00% |
| Sept. 9, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Restricted Stock Unit | 2462 | $0.00 | 32,007.0000 | 0 | 7.14% | 0.00% |
| Sept. 11, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 904 | $4.62 | 12,330.0000 | 0 | 6.83% | 0.00% |
| Sept. 9, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Class A Common Stock | 2462 | $0.00 | 13,234.0000 | 0 | 22.86% | 0.00% |
| Sept. 1, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Class A Common Stock | 717 | $0.00 | 11,041.0000 | 0 | 6.94% | 0.00% |
| Sept. 1, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Restricted Stock Unit | 717 | $0.00 | 8,608.0000 | 0 | 7.69% | 0.00% |
| Sept. 5, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 269 | $4.38 | 10,772.0000 | 0 | 2.44% | 0.00% |
| June 16, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Restricted Stock Unit | 7197 | $0.00 | 107,954.0000 | 0 | 6.25% | 0.00% |
| June 20, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 107 | $6.30 | 10,324.0000 | 0 | 1.03% | 0.00% |
| June 20, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 2637 | $6.37 | 10,431.0000 | 0 | 20.18% | 0.00% |
| June 16, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Class A Common Stock | 7197 | $0.00 | 13,068.0000 | 0 | 122.59% | 0.00% |
| June 9, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Restricted Stock Unit | 2462 | $0.00 | 34,469.0000 | 0 | 6.67% | 0.00% |
| June 13, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 903 | $6.49 | 5,871.0000 | 0 | 13.33% | 0.00% |
| June 9, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Class A Common Stock | 2462 | $0.00 | 6,774.0000 | 0 | 57.10% | 0.00% |
| June 1, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Restricted Stock Unit | 718 | $0.00 | 9,325.0000 | 0 | 7.15% | 0.00% |
| June 2, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 263 | $7.00 | 4,312.0000 | 0 | 5.75% | 0.00% |
| June 1, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Class A Common Stock | 718 | $0.00 | 4,575.0000 | 0 | 18.62% | 0.00% |
| May 16, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 1516 | $6.50 | 3,856.0000 | 0 | 28.22% | 0.00% |
| April 29, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Restricted Stock Unit | 99432 | $0.00 | 298,295.0000 | 0 | 25.00% | 0.00% |
| April 29, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Class A Common Stock | 99432 | $0.00 | 177,292.0000 | 0 | 127.71% | 0.00% |
| April 26, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | A | Restricted Stock Unit | 3800000 | $0.00 | 3,800,000.0000 | 0 | 9999.99% | 0.00% |
| March 9, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Restricted Stock Unit | 81250 | $0.00 | 1,218,750.0000 | 0 | 6.25% | 0.00% |
| March 9, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Class A Common Stock | 81250 | $0.00 | 109,736.0000 | 0 | 285.23% | 0.00% |
| March 10, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 31876 | $0.36 | 77,860.0000 | 0 | 29.05% | 0.00% |
| March 2, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | S | Class A Common Stock | 10397 | $0.45 | 28,486.0000 | 0 | 26.74% | 0.00% |
| March 1, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Class A Common Stock | 23674 | $0.00 | 38,883.0000 | 0 | 155.66% | 0.00% |
| March 1, 2023 | GeneDx Holdings Corp. | $WGS | Feeley Kevin | Chief Financial Officer | M | Restricted Stock Unit | 23674 | $0.00 | 331,439.0000 | 0 | 6.67% | 0.00% |